{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:35:46Z","timestamp":1789875346351,"version":"4.0.1"},"reference-count":178,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbcan.2025.189381","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:28:22Z","timestamp":1751581702000},"page":"189381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma"],"prefix":"10.1016","volume":"1880","author":[{"given":"Wanyue","family":"Dan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenxi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzhou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189381_bb0005","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.21037\/jgo-21-624","article-title":"Correlation of ulcerative colitis and colorectal cancer: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0010","doi-asserted-by":"crossref","first-page":"5363261","DOI":"10.1155\/2019\/5363261","article-title":"Risk of colorectal cancer in ulcerative colitis patients: a systematic review and meta-analysis","volume":"2019","author":"Zhou","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.bbcan.2025.189381_bb0015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbcan.2025.189381_bb0020","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.cgh.2019.05.062","article-title":"Belgian inflammatory bowel disease R, development G, risk of development of more-advanced lesions in patients with inflammatory bowel diseases and dysplasia","volume":"18","author":"Cremer","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0025","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1097\/SLA.0000000000005339","article-title":"Survival outcomes and clinicopathological features in inflammatory bowel disease-associated colorectal cancer: a systematic review and meta-analysis","volume":"276","author":"Lu","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2025.189381_bb0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"Olen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2025.189381_bb0035","first-page":"475","article-title":"Colorectal cancer in Crohn\u2019s disease: a Scandinavian population-based cohort study, lancet","volume":"5","author":"Olen","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0040","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.14309\/ajg.0000000000001941","article-title":"Inflammatory bowel disease-associated colorectal cancer epidemiology and outcomes: an English population-based study","volume":"117","author":"Birch","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","article-title":"Gut flora in health and disease","volume":"361","author":"Guarner","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbcan.2025.189381_bb0050","doi-asserted-by":"crossref","first-page":"2028366","DOI":"10.1080\/19490976.2022.2028366","article-title":"A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach","volume":"14","author":"Barberio","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2025.189381_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/gutjnl-2020-321106","article-title":"Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study","volume":"70","author":"Clooney","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8914","article-title":"Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome","volume":"10","author":"Vich Vila","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189381_bb0065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","article-title":"The treatment-naive microbiome in new-onset Crohn\u2019s disease","volume":"15","author":"Gevers","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbcan.2025.189381_bb0070","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/gutjnl-2014-308341","article-title":"Geographical patterns of the standing and active human gut microbiome in health and IBD","volume":"65","author":"Rehman","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0080","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41467-020-15342-5","article-title":"Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease","volume":"11","author":"Ryan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189381_bb0085","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ajg.2015.149","article-title":"Fecal microbiota in Pediatric inflammatory bowel disease and its relation to inflammation","volume":"110","author":"Kolho","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0090","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ecco-jcc\/jjv147","article-title":"Altered Fecal microbiota in paediatric inflammatory bowel disease","volume":"9","author":"Maukonen","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0095","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","article-title":"Fungal microbiota dysbiosis in IBD","volume":"66","author":"Sokol","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0100","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gutjnl-2018-318131","article-title":"Gut mucosal virome alterations in ulcerative colitis","volume":"68","author":"Zuo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/19490976.2018.1511664","article-title":"Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease","volume":"10","author":"Ungaro","year":"2019","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2025.189381_bb0110","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/gutjnl-2014-307873","article-title":"Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers","volume":"64","author":"Lavelle","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41591-018-0308-z","article-title":"Microbial network disturbances in relapsing refractory Crohn\u2019s disease","volume":"25","author":"Yilmaz","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2025.189381_bb0120","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1136\/gutjnl-2013-306226","article-title":"Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn\u2019s disease and their unaffected siblings","volume":"63","author":"Hedin","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","article-title":"Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease","volume":"67","author":"Imhann","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0130","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/ecco-jcc\/jjz049","article-title":"Faecal microbiota dynamics and their relation to disease course in Crohn\u2019s disease","volume":"13","author":"Galazzo","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0135","article-title":"Integrative multi-omics deciphers the spatial characteristics of host-gut microbiota interactions in Crohn\u2019s disease","volume":"4","author":"Gao","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2025.189381_bb0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/ecco-jcc\/jjv209","article-title":"Fungal Dysbiosis in mucosa-associated microbiota of Crohn\u2019s disease patients","volume":"10","author":"Liguori","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0145","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ecco-jcc\/jjw197","article-title":"Fungal microbiota profile in newly diagnosed treatment-na\u00efve children with Crohn\u2019s disease","volume":"11","author":"El Mouzan","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","article-title":"Malassezia is associated with Crohn\u2019s disease and exacerbates colitis in mouse models","volume":"25","author":"Limon","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbcan.2025.189381_bb0155","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1038\/s41467-022-34405-3","article-title":"Faecal microbiome-based machine learning for multi-class disease diagnosis","volume":"13","author":"Su","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189381_bb0160","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/gut.2005.078824","article-title":"Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease","volume":"55","author":"Conte","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2005.073817","article-title":"Reduced diversity of faecal microbiota in Crohn\u2019s disease revealed by a metagenomic approach","volume":"55","author":"Manichanh","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0170","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2025.189381_bb0175","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","article-title":"Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review","volume":"158","author":"Pittayanon","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/gut.2003.025403","article-title":"Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease","volume":"53","author":"Ott","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0185","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/ecco-jcc\/jjv147","article-title":"Altered fecal microbiota in paediatric inflammatory bowel disease","volume":"9","author":"Maukonen","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/gutjnl-2012-303207","article-title":"Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis","volume":"63","author":"Johansson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0195","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/gutjnl-2014-307873","article-title":"Spatial variation of the colonic microbiota in patients with ulcerativ e colitis and control volunteers","volume":"64","author":"Lavelle","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0200","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1053\/j.gastro.2021.08.057","article-title":"Dynamic properties of the intestinal ecosystem call for combination therapies, targeting inflammation and microbiota, in ulcerative colitis","volume":"161","author":"van de Guchte","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0205","article-title":"Metagenome analysis of intestinal bacteria in healthy people, patients with inflammatory bowel disease and colorectal cancer","volume":"11","author":"Ma","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146266","article-title":"Distinct effects of TU-100 (daikenchuto) on long-lasting dysbiosis in the small intestine in patients with colorectal cancer and inflammatory bowel disease","volume":"820","author":"Kono","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.bbcan.2025.189381_bb0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12223-023-01072-w","article-title":"Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer","volume":"69","author":"Acar","year":"2024","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0220","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1007\/s11033-020-05807-7","article-title":"Detection of streptococcus gallolyticus in colorectal cancer and inflammatory bowel disease patients compared to control group in southwest of Iran","volume":"47","author":"Sheikh","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbcan.2025.189381_bb0225","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MIB.0000000000000590","article-title":"Changes in the abundance of Faecalibacterium prausnitzii phylogroups I and II in the intestinal mucosa of inflammatory bowel disease and patients with colorectal cancer","volume":"22","author":"Lopez-Siles","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbcan.2025.189381_bb0230","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2013-304739","article-title":"Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli ex pressing lpfA and pks are increased in inflammatory bowel disease and colon cancer","volume":"63","author":"Prorok-Hamon","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0235","doi-asserted-by":"crossref","first-page":"2078620","DOI":"10.1080\/19490976.2022.2078620","article-title":"Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer","volume":"14","author":"Lavelle","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2025.189381_bb0240","first-page":"445","article-title":"Prevalence and phylogenetic analysis of Fusobacterium nucleatum and virulent factor FadA among ulcerative colitis precancerous and colorectal carcinoma patients in the Iraqi Kurdish population","volume":"78","author":"Taher","year":"2023","journal-title":"Arch. Razi Inst."},{"key":"10.1016\/j.bbcan.2025.189381_bb0245","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00284-023-03398-7","article-title":"Detection of fusobacterium nucleatum in patients with colitis-associated colorectal cancer","volume":"80","author":"Dregelies","year":"2023","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0250","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/ecco-jcc\/jjad092","article-title":"Bacterial oncotraits rather than spatial organization are associated with dysplasia in ulcerative colitis","volume":"17","author":"Bruggeling","year":"2023","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0255","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.3390\/molecules27185838","article-title":"A comprehensive analysis of microflora and metabolites in the development of ulcerative colitis into colorectal cancer based on the lung-gut correlation theory","volume":"27","author":"Tang","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.bbcan.2025.189381_bb0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fcimb.2018.00281","article-title":"Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects","volume":"8","author":"Lopez-Siles","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0265","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1038\/srep04985","article-title":"Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer","volume":"4","author":"Liang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189381_bb0270","doi-asserted-by":"crossref","first-page":"6645970","DOI":"10.1155\/2021\/6645970","article-title":"Gut Dysbiosis and abnormal bile acid metabolism in colitis-associated cancer","volume":"2021","author":"Liu","year":"2021","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.bbcan.2025.189381_bb0275","doi-asserted-by":"crossref","first-page":"1082835","DOI":"10.3389\/fmicb.2022.1082835","article-title":"Integrated analysis of the gut microbiome and metabolome in a mouse model of inflammation-induced colorectal tumors","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2020.461503","article-title":"Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: the combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer","volume":"1629","author":"Tang","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.bbcan.2025.189381_bb0285","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal cancer in inflammatory bowel disease: mechanisms and management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41392-021-00535-1","article-title":"GOLM1 restricts colitis and colon tumorigenesis by ensuring notch signaling equilibrium in intestinal homeostasis","volume":"6","author":"Pu","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189381_bb0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","article-title":"Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care","volume":"166","author":"Gilliland","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0300","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/jinfdis\/jiq061","article-title":"Perspective: alpha-bugs, their microbial partners, and the link to colon cancer","volume":"203","author":"Sears","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbcan.2025.189381_bb0305","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrmicro2819","article-title":"A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects","volume":"10","author":"Tjalsma","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12929-018-0483-8","article-title":"Microbiota dysbiosis and barrier dysfunction in inflammatory bowel dis ease and colorectal cancers: exploring a common ground hypothesis","volume":"25","author":"Yu","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbcan.2025.189381_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111712","article-title":"Microbiota from patients with ulcerative colitis promote colorectal carcinogenesis in mice","volume":"102","author":"Tian","year":"2022","journal-title":"Nutrition"},{"key":"10.1016\/j.bbcan.2025.189381_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111206","article-title":"Role of the global gut microbial community in the development of colitis-associated cancer in a murine model","volume":"135","author":"Lee","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189381_bb0325","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/s41467-023-37590-x","article-title":"FADS1-arachidonic acid axis enhances arachidonic acid metabolism by altering intestinal microecology in colorectal cancer","volume":"14","author":"Xu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189381_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70040","article-title":"Gut microbiota-derived butyrate mediates the anticolitic effect of indigo supplementation through regulating CD4+ T cell differentiation","volume":"4","author":"Xing","year":"2025","journal-title":"Imeta"},{"key":"10.1016\/j.bbcan.2025.189381_bb0335","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.05.050","article-title":"Commensal-specific CD4(+) cells from patients with Crohn\u2019s disease have a T-helper 17 inflammatory profile","volume":"151","author":"Calder\u00f3n-G\u00f3mez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0340","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2008.10.018","article-title":"RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F","volume":"136","author":"Leppkes","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0345","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1136\/gutjnl-2011-300612","article-title":"Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice","volume":"60","author":"Jauch","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0350","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2016.03.039","article-title":"Defective intestinal mucin-type O-glycosylation causes spontaneous colitis-associated cancer in mice","volume":"151","author":"Bergstrom","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0355","doi-asserted-by":"crossref","first-page":"G1055","DOI":"10.1152\/ajpgi.00328.2004","article-title":"Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis","volume":"288","author":"Fukata","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0360","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.4049\/jimmunol.178.10.6522","article-title":"Gnotobiotic IL-10\u2212\/\u2212;NF-kappa B(EGFP) mice reveal the critical role of TLR\/NF-kappa B signaling in commensal bacteria-induced colitis","volume":"178","author":"Karrasch","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0365","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ibd.20880","article-title":"Innate immune signaling by toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors","volume":"15","author":"Fukata","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbcan.2025.189381_bb0370","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.gastro.2020.10.031","article-title":"Epithelial TLR4 Signaling activates DUOX2 to induce microbiota-driven tumorigenesis","volume":"160","author":"Burgue\u00f1o","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm3233","article-title":"Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites","volume":"378","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2025.189381_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106101","article-title":"Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization","volume":"177","author":"Guo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbcan.2025.189381_bb0385","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/2159-8290.CD-15-0447","article-title":"Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis","volume":"5","author":"Geis","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2025.189381_bb0390","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/mi.2016.53","article-title":"The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis","volume":"10","author":"Thiele Orberg","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0395","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","article-title":"Enterotoxigenic bacteroidesfragilis promotes intestinal inflammation and malignancy by inhibiting exosome-packaged miR-149-3p","volume":"161","author":"Cao","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0400","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7150\/ijms.38371","article-title":"Enterotoxigenic Bacteroides fragilis infection exacerbates tumorigenesis in AOM\/DSS mouse model","volume":"17","author":"Hwang","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbcan.2025.189381_bb0405","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/08923973.2019.1569047","article-title":"The germ-free mice monocolonization with Bacteroides fragilis improves azoxymethane\/dextran sulfate sodium induced colitis-associated colorectal cancer","volume":"41","author":"Lee","year":"2019","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0410","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2021.10.002","article-title":"Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis","volume":"523","author":"Shao","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189381_bb0415","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41385-018-0085-5","article-title":"Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A","volume":"12","author":"Chan","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0420","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1126\/science.aad9948","article-title":"Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease","volume":"352","author":"Chu","year":"2016","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbcan.2025.189381_bb0425","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00587-18","article-title":"The protective role of Bacteroides fragilis in a murine model of colitis-associated colorectal cancer","volume":"3","author":"Lee","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.bbcan.2025.189381_bb0430","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/0960327120954249","article-title":"Toll-like receptor 4 prevents AOM\/DSS-induced colitis-associated colorectal cancer in Bacteroides fragilis gnotobiotic mice","volume":"40","author":"Lee","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0435","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","article-title":"A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche","volume":"628","author":"Zepeda-Rivera","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189381_bb0440","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbcan.2025.189381_bb0445","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41467-022-28913-5","article-title":"Fusobacterium nucleatum reduces METTL3-mediated m(6)a modification and contributes to colorectal cancer metastasis","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189381_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104964","article-title":"Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes","volume":"157","author":"Li","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bbcan.2025.189381_bb0455","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1136\/gutjnl-2015-310101","article-title":"Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis","volume":"65","author":"Mima","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0460","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3748\/wjg.v28.i18.1981","article-title":"Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model","volume":"28","author":"Wu","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0465","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/1751-2980.12909","article-title":"Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation","volume":"21","author":"Liu","year":"2020","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.bbcan.2025.189381_bb0470","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/cancers12102728","article-title":"Fusobacterium nucleatum accelerates the progression of colitis-associated colorectal cancer by promoting EMT","volume":"12","author":"Yu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189381_bb0475","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7150\/thno.38870","article-title":"Fusobacterium nucleatum promotes metastasis in colorectal cancer by activating autophagy signaling via the upregulation of CARD3 expression","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189381_bb0480","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","article-title":"Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-\u03baB, and up-regulating expression of MicroRNA-21","volume":"152","author":"Yang","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0485","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.21873\/anticanres.15910","article-title":"Chitinase 3-like 1, carcinoembryonic antigen-related cell adhesion molecule 6, and ectopic Claudin-2 in the carcinogenic processes of ulcerative colitis","volume":"42","author":"Kinugasa","year":"2022","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2025.189381_bb0490","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli","volume":"580","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189381_bb0495","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41591-020-0908-2","article-title":"Colibactin DNA-damage signature indicates mutational impact in colorectal cancer","volume":"26","author":"Dziuba\u0144ska-Kusibab","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2025.189381_bb0500","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3390\/cancers13092060","article-title":"Colibactin-producing Escherichia coli induce the formation of invasive carcinomas in a chronic inflammation-associated mouse model","volume":"13","author":"Salesse","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189381_bb0505","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1136\/gutjnl-2013-305257","article-title":"Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype","volume":"63","author":"Cougnoux","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0510","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4161\/19490976.2014.969989","article-title":"The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment","volume":"5","author":"Dalmasso","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2025.189381_bb0515","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02244-19","article-title":"Increased epithelial oxygenation links colitis to an expansion of Tumo rigenic bacteria","volume":"10","author":"Cevallos","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.bbcan.2025.189381_bb0520","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbrc.2018.10.136","article-title":"Streptococcus gallolyticus conspires myeloid cells to promote tumorigenesis of inflammatory bowel disease","volume":"506","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189381_bb0525","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7150\/jca.63578","article-title":"Akkermansia muciniphila administration exacerbated the development of colitis-associated colorectal cancer in mice","volume":"13","author":"Wang","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189381_bb0530","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13099-020-00396-z","article-title":"Eubacterium rectale contributes to colorectal cancer initiation via promoting colitis","volume":"13","author":"Wang","year":"2021","journal-title":"Gut Pathog."},{"key":"10.1016\/j.bbcan.2025.189381_bb0535","doi-asserted-by":"crossref","first-page":"478","DOI":"10.21037\/atm-22-1670","article-title":"Clostridium butyricum inhibits the progression of colorectal cancer and alleviates intestinal inflammation via the myeloid differentiation factor 88 (MyD88)-nuclear factor-kappa B (NF-\u03baB) signaling pathway","volume":"10","author":"Zhou","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189381_bb0540","doi-asserted-by":"crossref","first-page":"1004756","DOI":"10.3389\/fimmu.2023.1004756","article-title":"Inhibitory effects of Clostridium butyricum culture and supernatant on inflammatory colorectal cancer in mice","volume":"14","author":"Pu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0545","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2018.08.024","article-title":"SYK-CARD9 signaling axis promotes gut fungi-mediated inflammasome activation to restrict colitis and colon cancer","volume":"49","author":"Malik","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189381_bb0550","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.immuni.2018.08.018","article-title":"The adaptor protein CARD9 protects against colon cancer by restricting mycobiota-mediated expansion of myeloid-derived suppressor cells","volume":"49","author":"Wang","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189381_bb0555","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/apt.16656","article-title":"Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease","volume":"55","author":"Radhakrishnan","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189381_bb0560","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ecco-jcc\/jjaa143","article-title":"Gut microbiota-driven drug metabolism in inflammatory bowel disease","volume":"15","author":"Crouwel","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0565","doi-asserted-by":"crossref","first-page":"16267","DOI":"10.1038\/nmicrobiol.2016.267","article-title":"The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulation","volume":"2","author":"Dahl","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0570","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2036.2011.04732.x","article-title":"Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome","volume":"34","author":"Andrews","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189381_bb0575","article-title":"Gut microbiota and related metabolites were disturbed in ulcerative colitis and partly restored after Mesalamine treatment","volume":"11","author":"Dai","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0580","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00018-022-04471-3","article-title":"5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism","volume":"79","author":"Huang","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2025.189381_bb0585","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41591-023-02217-7","article-title":"Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease","volume":"29","author":"Mehta","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2025.189381_bb0590","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s13258-020-00986-w","article-title":"High-throughput sequencing analysis of differences in intestinal microflora between ulcerative colitis patients with different glucocorticoid response types","volume":"42","author":"Zhu","year":"2020","journal-title":"Genes Genom."},{"key":"10.1016\/j.bbcan.2025.189381_bb0595","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2013.09.007","article-title":"Colonic bacterial metabolism of corticosteroids","volume":"457","author":"Yadav","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbcan.2025.189381_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.879170","article-title":"Gut microbiota metabolism of azathioprine: a new Hallmark for personalized drug-targeted therapy of chronic inflammatory bowel disease","volume":"13","author":"Lazarevi\u0107","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0605","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/ibd\/izy126","article-title":"Anti-TNF therapy induces CD4+ T-cell production of IL-22 and promotes epithelial repairs in patients with Crohn\u2019s disease","volume":"24","author":"Fang","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbcan.2025.189381_bb0610","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2019.07.025","article-title":"Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases","volume":"157","author":"Aden","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0615","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ecco-jcc\/jjv119","article-title":"Anti-tumour necrosis factor treatment with Adalimumab induces changes in the microbiota of Crohn\u2019s disease","volume":"9","author":"Busquets","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0620","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/ibd\/izab273","article-title":"RAID prediction: pilot study of Fecal microbial signature with capacity to predict response to anti-TNF treatment","volume":"27","author":"Busquets","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbcan.2025.189381_bb0625","article-title":"Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn\u2019s disease","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0630","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/ecco-jcc\/jjw051","article-title":"Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota com position","volume":"10","author":"Magnusson","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0635","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2019.02.020","article-title":"Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota","volume":"80","author":"Sougiannis","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbcan.2025.189381_bb0640","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","article-title":"Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy","volume":"170","author":"Yu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189381_bb0645","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.7150\/thno.70754","article-title":"Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis","volume":"12","author":"Ghosh","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189381_bb0650","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/ecco-jcc\/jjac173","article-title":"Increased primary bile acids with ileocolonic resection impact ileal inflammation and gut microbiota in inflammatory bowel disease","volume":"17","author":"Battat","year":"2023","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0655","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/gutjnl-2015-309184","article-title":"Structural robustness of the gut mucosal microbiota is associated with Crohn\u2019s disease remission after surgery","volume":"65","author":"Mondot","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0660","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/gutjnl-2019-318719","article-title":"Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn\u2019s disease","volume":"69","author":"Sokol","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0665","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/ecco-jcc\/jjaa081","article-title":"Early postoperative endoscopic recurrence in Crohn\u2019s disease is characterised by distinct microbiota recolonisation","volume":"14","author":"Machiels","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0670","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ecco-jcc\/jjac026","article-title":"Impact of the Ileal microbiota on surgical site infections in Crohn\u2019s disease: a nationwide prospective cohort","volume":"16","author":"Julien","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0675","article-title":"Probiotics for induction of remission in ulcerative colitis","volume":"3","author":"Kaur","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbcan.2025.189381_bb0680","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","article-title":"Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189381_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117927","article-title":"The protective effect of lactobacillus versus 5-aminosalicylic acid in ulcerative colitis model by modulation of gut microbiota and Nrf2\/Ho-1 pathway","volume":"256","author":"El-Baz","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2025.189381_bb0690","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/gut.2005.078303","article-title":"Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis","volume":"55","author":"K\u00fchbacher","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0695","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0016-5085(03)00171-9","article-title":"Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial","volume":"124","author":"Gionchetti","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0700","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41467-024-44776-4","article-title":"Engineering tumor-colonizing E. coli Nissle 1917 For detection and treatment of colorectal neoplasia","volume":"15","author":"Gurbatri","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189381_bb0705","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/nu14091916","article-title":"Lactiplantibacillus plantarum-12 alleviates inflammation and colon cancer symptoms in AOM\/DSS-treated mice through modulating the intestinal microbiome and metabolome","volume":"14","author":"Ma","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbcan.2025.189381_bb0710","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.3748\/wjg.v26.i43.6782","article-title":"Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane\/dextran sodium sulfate model","volume":"26","author":"Silveira","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0715","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.3748\/wjg.v24.i37.4254","article-title":"VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice","volume":"24","author":"Wang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0720","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13046-023-02746-6","article-title":"Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis","volume":"42","author":"Lin","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189381_bb0725","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cac2.12469","article-title":"Bifidobacterium adolescentis orchestrates CD143+ cancer-associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling-regulated GAS1","volume":"43","author":"Chen","year":"2023","journal-title":"Cancer Commun. (London, England)"},{"key":"10.1016\/j.bbcan.2025.189381_bb0730","doi-asserted-by":"crossref","first-page":"1785803","DOI":"10.1080\/19490976.2020.1785803","article-title":"Cancer-protective effect of a synbiotic combination between lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer","volume":"12","author":"Oh","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2025.189381_bb0735","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1039\/D1FO02939H","article-title":"Lactobacillus kefiranofaciens JKSP109 and Saccharomyces cerevisiae JKSP39 isolated from Tibetan kefir grain co-alleviated AOM\/DSS induced inflammation and colorectal carcinogenesis","volume":"13","author":"Zeng","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.bbcan.2025.189381_bb0740","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s40168-021-01071-4","article-title":"A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota","volume":"9","author":"Chung","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.bbcan.2025.189381_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.562189","article-title":"Inhibitory effect of a microecological preparation on azoxymethane\/dextran sodium sulfate-induced inflammatory colorectal cancer in mice","volume":"10","author":"Yu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0750","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/nu5041417","article-title":"Fiber and prebiotics: mechanisms and health benefits","volume":"5","author":"Slavin","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.bbcan.2025.189381_bb0755","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/gutjnl-2023-329948","article-title":"The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease","volume":"72","author":"Lopetuso","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189381_bb0760","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0765","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2025.189381_bb0770","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of Fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2025.189381_bb0775","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S2468-1253(21)00433-7","article-title":"Oral lyophilised microbiota for the treatment of ulcerative colitis","volume":"7","author":"Fischer","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0780","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to Fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0785","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2021.09.061","article-title":"Transferable immunoglobulin A-coated Odoribacter splanchnicus in responders to Fecal microbiota transplantation for ulcerative colitis limits colonic inflammation","volume":"162","author":"Lima","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0790","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1053\/j.gastro.2020.08.045","article-title":"Linking strain engraftment in Fecal microbiota transplantation with maintenance of remission in Crohn\u2019s disease","volume":"159","author":"Kong","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0795","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.chom.2020.03.006","article-title":"Fungal trans-kingdom dynamics linked to responsiveness to Fecal microb iota transplantation (FMT) therapy in ulcerative colitis","volume":"27","author":"Leonardi","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbcan.2025.189381_bb0800","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.3389\/fmicb.2019.02498","article-title":"Protective role of Fecal microbiota transplantation on colitis and colitis-associated colon cancer in mice is associated with treg cells","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115647","article-title":"The pharmacological validation of the Xiao-Jian-Zhong formula against ulcerative colitis by network pharmacology integrated with metabolomics","volume":"298","author":"Yu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116125","article-title":"The san-Qi-Xue-Shang-Ning formula protects against ulcerative colitis by restoring the homeostasis of gut immunity and microbiota","volume":"305","author":"Yu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118231","article-title":"Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon","volume":"267","author":"Guo","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bbcan.2025.189381_bb0820","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.797605","article-title":"Amelioration of AOM\/DSS-induced murine colitis-associated cancer by evodiamine intervention is primarily associated with gut microbiota-metabolism-inflammatory signaling axis","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0825","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/nu14040726","article-title":"Pre-administration of berberine exerts chemopreventive effects in AOM\/DSS-induced colitis-associated carcinogenesis mice via modulating inflammation and intestinal microbiota","volume":"14","author":"Deng","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbcan.2025.189381_bb0830","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12885-022-09635-9","article-title":"Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189381_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588079","article-title":"A holistic view of berberine inhibiting intestinal carcinogenesis in conventional mice based on microbiome-metabolomics analysis","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0840","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.3390\/nu12072156","article-title":"Efficacy of dietary supplements in inflammatory bowel disease and related autoimmune diseases","volume":"12","author":"Jadhav","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbcan.2025.189381_bb0845","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/s41598-017-07992-1","article-title":"Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis","volume":"7","author":"Prossomariti","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189381_bb0850","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.14291","article-title":"Systematic review with meta-analysis: breastfeeding and the risk of Crohn\u2019s disease and ulcerative colitis","volume":"46","author":"Xu","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189381_bb0855","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.7150\/thno.62046","article-title":"Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota","volume":"11","author":"Tong","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189381_bb0860","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.07.050","article-title":"A prospective study of long-term intake of dietary fiber and risk of Crohn\u2019s disease and ulcerative colitis","volume":"145","author":"Ananthakrishnan","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189381_bb0865","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nutres.2020.01.002","article-title":"Mango (Mangifera indica L.) polyphenols reduce IL-8, GRO, and GM-SCF plasma levels and increase lactobacillus species in a pilot study in patients with inflammatory bowel disease","volume":"75","author":"Kim","year":"2020","journal-title":"Nutr. Res."},{"key":"10.1016\/j.bbcan.2025.189381_bb0870","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.intimp.2019.02.038","article-title":"A unique polysaccharide from Hericium erinaceus mycelium ameliorates acetic acid-induced ulcerative colitis rats by modulating the composition of the gut microbiota, short chain fatty acids levels and GPR41\/43 respectors","volume":"71","author":"Shao","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2025.189381_bb0875","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/carcin\/bgaa100","article-title":"Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM\/DSS mice","volume":"42","author":"Terasaki","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2025.189381_bb0880","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1039\/D2FO03207D","article-title":"A special polysaccharide hydrogel coated on Brasenia schreberi: preventive effects against ulcerative colitis via modulation of gut microbiota","volume":"14","author":"Wan","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.bbcan.2025.189381_bb0885","first-page":"1900610","article-title":"A proresolving peptide nanotherapy for site-specific treatment of inflammatory bowel disease by regulating Proinflammatory microenvironment and gut microbiota","volume":"6","author":"Li","year":"2019","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bbcan.2025.189381_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101300","article-title":"Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn\u2019s disease: a randomized controlled trial","volume":"45","author":"Bao","year":"2022","journal-title":"EClinicalMedicine"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:58:05Z","timestamp":1761944285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25001234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":178,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0304419X25001234"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189381","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189381"}}